VEGF, fetal liver kinase-1, and permeability increase during unilateral lung ischemia

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 279, Issue 3 23-3, 2000, Pages

  Kazi, Armina A ^a   Lee, Won S ^a   Wagner, Elizabeth ^a   Becker, Patrice M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Acute lung injury; Fetal liver kinase 1; Pulmonary arterial occlusion; Pulmonary edema; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ANIMAL MODEL; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FETUS LIVER; GENE OVEREXPRESSION; ISCHEMIA; LUNG EDEMA; LUNG INJURY; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY OCCLUSION; REVIEW;

EID: 0033826993     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2000.279.3.l460     Document Type: Review

References (51)

1. Vascular endothelial growth factor gene expression in human fetal lung in vitro
2. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
3. Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription
4. Oxygen-independent upregulation of vascular endothelial growth factor and vascular barrier dysfunction during ventilated pulmonary ischemia in isolated ferret lungs
5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
6. Induction of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation
7. Angiogenesis in bronchial circulatory system after unilateral pulmonary artery obstruction
8. CD4+ T lymphocyte modulation of ozone-induced murine pulmonary inflammation
9. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension
10. 2 in rat heart endothelial cells
11. Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat
12. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells
13. Vascular endothelial growth factor induces endothelial fenestrations in vitro
14. Molecular and biological properties of vascular endothelial growth factor
15. Hetereozygous embryonic lethality induced by targeted inactiration of the VEGF gene
16. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation
17. Regulation of VEGF expression in cultured keratinocytes. Implications for normal and impaired wound healing
18. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart
19. VEGF induces hyperpermeability by a direct action on endothelial cells
20. Pulmonary artery occlusion. II. Morphologic studies
21. Microvascular injury distal to unilateral pulmonary artery occlusion
22. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins
23. VEGF and flt expression time kinetics in rat brain infarct
24. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo
25. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
26. Site of pulmonary edema after unilateral microembolization
27. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) after permanent and transient occlusion of the middle cerebral artery in the rat
28. Posttranscriptional regulation of vascular endothelial growth factor by hypoxia
29. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
30. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR
31. VEGF, flk-1 and flt-1 expression in a rat myocardial infarction model of angiogenesis
32. Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung
33. Increased resistance in postobstructive pulmonary vasculopathy: Structure-function relationships
34. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo
35. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
36. Angiogenesis in the mouse lung
37. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues
38. Vascular endothelial growth factor upregulation in human central retinal vein occlusion
39. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
40. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by hetereogeneous nuclear ribonucleoprotein L
41. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis
42. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia
43. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
44. Increased expression of KDP/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization
45. Increased gene expression of VEGF and the VEGF receptors KDP/Flk and Flt in lungs exposed to acute or to chronic hypoxia
46. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain
47. Vascular endothelial growth factor affects permeability of brain microvessel endothelial cells in vitro
48. Early stages in the development of collateral circulation to the lung in the rat
49. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
50. VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo